21 – 30 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Glucose effectiveness : Lessons from studies on insulin-independent glucose clearance in mice
- Contribution to journal › Scientific review
-
Mark
Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test
- Contribution to journal › Article
-
Mark
Glucagon-like peptide-1 and beta cell glucose sensitivity - a glucose ramp study in mice
- Contribution to journal › Article
-
Mark
Glucose-lowering action through targeting islet dysfunction in type 2 diabetes : Focus on dipeptidyl peptidase-4 inhibition
- Contribution to journal › Scientific review
- 2020
-
Mark
Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetes
- Contribution to journal › Article
-
Mark
On Meal Effects and DPP-4 Inhibition Islet- and Incretin Hormones in Health and Type 2 Diabetes
(2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
The incretin effect in female mice with double deletion of GLP-1 and GIP receptors
- Contribution to journal › Article
-
Mark
Consequences on islet and incretin hormone responses to dinner by omission of lunch in healthy men
- Contribution to journal › Article
- 2019
-
Mark
Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice
(2019) In American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 316(1). p.27-37
- Contribution to journal › Article
-
Mark
Glucagon-like peptide-1 receptor agonists for type 2 diabetes : A rational drug development
- Contribution to journal › Article
